Friday 16 November, 2018

Health Ministry confirms: No recalls on Valsartan products

There has been no recalls on Valsartan products currently procured through the Ministry of Health, Trinidad and Tobago for the public and private sector.

This, according to a statement released on Thursday by the Ministry. 

On July 17, the United States Food and Drugs Administration (U.S. FDA) issued an update alerting members of the public of a voluntary recall of several drug products containing the active ingredient Valsartan. The recalled products were found to contain the impurity and probable human carcinogen, N-nitrosodiumethylamine (NDMA).

However, none of the Valsartan products registered for use in Trinidad and Tobago are on the U.S. FDA list of recalled preparations.

The Ministry added that Valsartan has not been selected by cardiovascular specialists for use in the public system for the last two tender periods (2017/2018 and 2018/2019).



Get the latest local and international news straight to your mobile phone for free:

Download the Loop News Caribbean app on Google Play Store:

Download the Loop News Caribbean app on the App Store: